🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Kun He

Hebei Medical University

ORCID: 0000-0002-1510-860X

Also affiliated with Affiliated Hospital of Southwest Medical University, Fourth Hospital of Hebei Medical University, First Hospital of Shijiazhuang

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “533 An open label Phase IA/IB study for safety, pharmacokinetics (PK), and efficacy of ONC 392 as a single agent and in combination with Pembrolizumab in advanced solid tumors”.

533 An open label Phase IA/IB study for safety, pharmacokinetics (PK), and efficacy of ONC 392 as a single agent and in combination with Pembrolizumab in advanced solid tumors

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.533
N/A
0DataRank · unranked
0 citations

Kun He, Yang Liu, Pan Zheng